Supernus Pharmaceuticals, Inc. (SUPN)
50.86
-2.36
(-4.43%)
USD |
NASDAQ |
Mar 12, 13:19
Supernus Pharmaceuticals Shareholders Equity (Quarterly) : 1.062B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| BridgeBio Pharma, Inc. | -2.087B |
| Corcept Therapeutics, Inc. | 647.80M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Cytokinetics, Inc. | -659.62M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.614B |
| Total Liabilities (Quarterly) | 552.44M |
| Debt to Equity Ratio | 0.0386 |
| Current Ratio | 1.905 |
| Net Debt Paydown Yield | -0.02% |